Cancer drug danger? new study probes heart risks of immunotherapy
NCT ID NCT06020651
First seen Apr 14, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study looked at how immune checkpoint inhibitors, a type of cancer drug, might harm blood vessels and speed up artery disease. Researchers followed 39 cancer patients before and after starting these drugs, using ultrasound and blood tests to track changes. The goal was to better understand the risks, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
INstitut Mutualiste Montsouris
Paris, France
Conditions
Explore the condition pages connected to this study.